Glasgow, United Kingdom · Founded 2021 · Privately Held (backing)
Developer of a medical diagnostic device designed to reduce deaths from drug-resistant infections. Microplate Dx is based in Glasgow, United Kingdom and was founded in 2021. It was valued at $11.9 million at its early-stage round in Sep 2025, the last priced event on record. It has raised $14 million across 2 recorded rounds; the latest was a $644,569 seed round in Sep 2025.
PMV mark · valuation
$11.9M
Oct 2026
Priced at
its early-stage round
Sep 2025
Total raised
$14.0M
Last round
Seed Round
Sep 2025
Cap table — not yet on record
Microplate Dx's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Microplate Dx with a free account
·The complete investor list: 15 names
·Watch Microplate Dx: the Monday email on marks, rounds and moves
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Microplate Dx's 2 recorded funding rounds.